Intuitive Surgical, Inc. $ISRG Shares Sold by Invesco Ltd.

Key Points

• Invesco Ltd. cut its stake in Intuitive Surgical by 20.4% (selling 903,666 shares) and now holds 3,517,467 shares—about 0.98% of the company—valued at roughly $1.573 billion.
• Intuitive Surgical beat Q4 expectations (EPS $2.53 vs. $2.27; revenue $2.87B, +18.8% y/y) and its da Vinci system received FDA clearance for cardiac surgery
• Despite strong results, insiders sold about 33,407 shares (~$17.5M) recently, management warned of procedure‑growth deceleration in 2026, and the stock trades at an elevated P/E ~60.7, posing near‑term valuation and sentiment risks.

Invesco Ltd. lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 20.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,517,467 shares of the medical equipment provider's stock after selling 903,666 shares during the quarter. Invesco Ltd. owned approximately 0.98% of Intuitive Surgical worth $1,573,117,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in ISRG. Rossmore Private Capital grew its holdings in shares of Intuitive Surgical by 2.0% during the third quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider's stock worth $446,000 after buying an additional 20 shares in the last quarter. Activest Wealth Management lifted its stake in shares of Intuitive Surgical by 21.7% during the third quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider's stock valued at $50,000 after buying an additional 20 shares during the period. Vertex Planning Partners LLC boosted its position in Intuitive Surgical by 2.3% during the second quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider's stock worth $498,000 after acquiring an additional 21 shares during the last quarter. Accredited Investors Inc. boosted its position in Intuitive Surgical by 2.0% during the third quarter. Accredited Investors Inc. now owns 1,060 shares of the medical equipment provider's stock worth $474,000 after acquiring an additional 21 shares during the last quarter. Finally, SPC Financial Inc. grew its stake in Intuitive Surgical by 1.3% in the 3rd quarter. SPC Financial Inc. now owns 1,614 shares of the medical equipment provider's stock worth $722,000 after acquiring an additional 21 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Stock Down 2.8%

Shares of ISRG opened at $479.27 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88. The company's fifty day moving average is $515.05 and its two-hundred day moving average is $512.37. The firm has a market cap of $170.20 billion, a PE ratio of 60.74, a price-to-earnings-growth ratio of 3.80 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping analysts' consensus estimates of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business's revenue for the quarter was up 18.8% on a year-over-year basis. During the same period in the prior year, the firm posted $2.21 EPS. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, SVP Patricia L. Wadors sold 220 shares of the company's stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $499.71, for a total transaction of $109,936.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Fredrik Widman sold 133 shares of the firm's stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $65,829.68. Following the completion of the transaction, the vice president owned 660 shares in the company, valued at approximately $326,673.60. This trade represents a 16.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 33,407 shares of company stock worth $17,534,067 in the last three months. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Citi upgraded ISRG to Buy with a $590 target, which boosts near‑term sentiment and signals analyst confidence in upside. Citigroup upgrades Intuitive Surgical (ISRG)
• Positive Sentiment: The da Vinci system won FDA clearance for cardiac surgery, opening a much larger TAM (from ~17k to ~160k potential procedures in cleared markets) — a material long‑term growth catalyst if adoption follows. ISRG's da Vinci Gains FDA Nod for Cardiac Surgery
• Positive Sentiment: Q4 results beat expectations (19% revenue growth, EPS beat) and management highlighted recurring revenue strength — these prints underpin the bullish analyst commentary and recent outperformance days. Intuitive Surgical Inc. stock outperforms competitors
• Neutral Sentiment: Long‑form bulls argue “massive growth ahead” from da Vinci 5, Ion and SP platforms — supportive for the multi‑year case but not a near‑term catalyst. Intuitive Surgical: The Robotic Surgery Leader Still Has Massive Growth Ahead
• Neutral Sentiment: Several valuation pieces note ISRG trades well above historical P/E levels, creating a tension between growth expectations and an elevated multiple — keeps the stock range‑bound absent fresh catalysts. Assessing Intuitive Surgical (ISRG) Valuation
• Negative Sentiment: Management guided for a deceleration in worldwide da Vinci procedure growth in 2026 — a notable near‑term headwind to growth expectations. Intuitive Surgical Stock: Buy, Sell, or Hold?
• Negative Sentiment: Insider selling (multiple senior exec trades in March) is visible and may be fueling profit‑taking and downside pressure despite strong public messaging. SEC filing: Insider Sale Disclosures
• Negative Sentiment: Stock has recently fallen more than the market on low‑volume sessions, indicating short‑term technical weakness and profit‑taking after the post‑earnings run. Intuitive Surgical Suffers a Larger Drop Than the General Market

Analyst Ratings Changes

Several research analysts have weighed in on the company. Citigroup upgraded Intuitive Surgical from a "neutral" rating to a "buy" rating and set a $590.00 price target for the company in a report on Wednesday. Sanford C. Bernstein lifted their price objective on Intuitive Surgical from $740.00 to $750.00 and gave the company an "outperform" rating in a research report on Friday, January 23rd. TD Cowen upgraded Intuitive Surgical to a "strong-buy" rating in a research note on Tuesday, January 27th. Piper Sandler reiterated an "overweight" rating and set a $620.00 target price (up from $610.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Finally, Wall Street Zen lowered Intuitive Surgical from a "buy" rating to a "hold" rating in a research note on Saturday, February 7th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus price target of $615.86.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.